Sotera Health Company
HealthcareNASDAQ:SHC · NASDAQ Global Select
-$0.20 today
Vol 1.44M · Avg 3.33M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
12.9%
avg -3.7%
ROIC
6.8%
avg 5.7%
ROA
2.4%
avg -0.0%
Analysis
ROE is currently the strongest return metric at 12.9% versus its period average of -3.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Michael Petras Jr. | Executive Chairman of the Board | $2.63M | — | 57 | $22,612.00 | <0.01% |
Jonathan Lyons | Senior Vice President & Chief Financial Officer | $999,111.00 | — | 48 | $201,493.00 | 0.07% |
Michael Rutz | President of Sterigenics U.S., LLC | $838,763.00 | — | 55 | $22,612.00 | <0.01% |
Joseph A. Shrawder | President of Nelson Labs | — | — | — | — | — |
Alton E. Shader | CEO & Director | — | — | 53 | $101,817.00 | 0.04% |
Robert G. Hauzie | Chief Information Officer | — | — | — | $54,933.00 | 0.02% |
William Lehmann Jr. | Senior Vice President of Strategy & Corporate Development | — | — | 60 | $692,427.00 | 0.24% |
Danielle J. Menture | Senior Vice President of Global Environmental, Health & Safety and Sustainability | — | — | — | $738,649.00 | 0.26% |
Erika Ostrowski | Senior VP, General Counsel & Corporate Secretary | — | — | — | $0.00 | <0.01% |
Kristin A. Gibbs | Chief Marketing Officer | — | — | — | — | — |
Sally R. Turner | Chief Human Resources Officer | — | — | — | $140,926.00 | 0.05% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
14
$1.92B
Net Sentiment
$1.92B
Net selling
Most Active
GTCR INVESTMENT XI LLC
5 transactions
1–10 of 14
Analysis
Insiders reported 0 buys worth $0.00 and 14 sells worth $1.92B over the last 12 months. That adds up to net selling of $1.92B. GTCR INVESTMENT XI LLC was the most active insider with 5 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +8.8% | +5.7% (7yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | +10.6% | +0.3% (7yr)2 analysts |
Analysis
Recent growth has been strongest in EBIT at +10.6% over three years. Forward estimates point to Revenue at +5.7% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Glaukos Corporation
NYSE:GKOS
$7.45B
Alkermes plc
NASDAQ:ALKS
$7.38B
Oscar Health, Inc.
NYSE:OSCR
$7.33B
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
$7.06B
Arcellx, Inc.
ACLX
$6.73B
Teleflex Incorporated
NYSE:TFX
$5.78B
Bausch + Lomb Corporation
NYSE:BLCO
$5.38B
Merit Medical Systems, Inc.
NASDAQ:MMSI
$3.97B
Option Care Health, Inc.
NASDAQ:OPCH
$3.26B
TransMedics Group, Inc.
NASDAQ:TMDX
$2.52B
Who manages SHC?
Sotera Health Company (SHC) lists 11 active executives. The top listed executive is Michael Petras Jr., Executive Chairman of the Board.
Are SHC insiders buying or selling?
Recent insider activity shows net selling of $3.34B.
Explore More
Continue the stock analysis
Jump to another research area for this company.